Delivery Order SPE2DB20D3103-SPE2DB25FP0C4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Scopolamine 1 mg/3 day patches (quantity 4) with a ceiling value of $1,362.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Scopolamine 1 mg/3 day patches (24-count) with a contract ceiling value of $1,662.03. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Scopolamine 1 mg/3 day patches (24-count units) under a firm fixed price contract valued at $4,490.44. The order, with an ultimate completion date of September 18, 2025, was competitively awarded without set-aside designations. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,235.46 to AmerisourceBergen Drug Corp for the supply of Scopolamine 1 mg/3 day patches (24-unit quantity) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,467.08 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Scopolamine 1 mg/3 day patches (10 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 25, 2025. The vendor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,257.37 to AmerisourceBergen Drug Corp for Scopolamine 1 mg/3 day patches (10-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Scopolamine 1 mg/3 day patches (24-count units) under a firm fixed-price contract with a ceiling value of $1,830.00. The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,213.74 to AmerisourceBergen Drug Corp for Scopolamine 1 mg/3 Day Patch in a quantity of 24 units. This contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Scopolamine 1 mg/3 day patches (24-count) valued at $1,765.94. The contract is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $6,048.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Scopolamine 1 mg/3 day patches in quantities of 24 units. The delivery order, which represents a competitively awarded non-set-aside contract, is scheduled for ultimate completion on July 24, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP0C4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,133.68 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Scopolamine 1 mg/3 Day patches (quantity: 4 units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military and veteran healthcare systems. Scopolamine patches are commonly used in medical settings for motion sickness and nausea prevention, making this a routine procurement within the company's extensive pharmaceutical delivery operations for the Defense Health Agency and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/30/25 |